Somatostatin Receptor Type 4 Market
1 Study Coverage
1.1 Somatostatin Receptor Type 4 Product Introduction
1.2 Global Somatostatin Receptor Type 4 Outlook 2017 VS 2022 VS 2028
1.2.1 Global Somatostatin Receptor Type 4 Sales in US$ Million for the Year 2017-2028
1.2.2 Global Somatostatin Receptor Type 4 Sales in Volume for the Year 2017-2028
1.3 United States Somatostatin Receptor Type 4 Outlook 2017 VS 2022 VS 2028
1.3.1 United States Somatostatin Receptor Type 4 Sales in US$ Million for the Year 2017-2028
1.3.2 United States Somatostatin Receptor Type 4 Sales in Volume for the Year 2017-2028
1.4 Somatostatin Receptor Type 4 Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Somatostatin Receptor Type 4 in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Somatostatin Receptor Type 4 Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Somatostatin Receptor Type 4 Market Dynamics
1.5.1 Somatostatin Receptor Type 4 Industry Trends
1.5.2 Somatostatin Receptor Type 4 Market Drivers
1.5.3 Somatostatin Receptor Type 4 Market Challenges
1.5.4 Somatostatin Receptor Type 4 Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Somatostatin Receptor Type 4 Market Segment by Type
2.1.1 CNTX-0290
2.1.2 NNC-26910
2.1.3 Veldoreotide
2.1.4 Others
2.2 Global Somatostatin Receptor Type 4 Market Size by Type
2.2.1 Global Somatostatin Receptor Type 4 Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Somatostatin Receptor Type 4 Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Somatostatin Receptor Type 4 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Somatostatin Receptor Type 4 Market Size by Type
2.3.1 United States Somatostatin Receptor Type 4 Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Somatostatin Receptor Type 4 Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Somatostatin Receptor Type 4 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Somatostatin Receptor Type 4 Market Segment by Application
3.1.1 Alzheimer's Disease
3.1.2 Cognitive Disorders
3.1.3 Neuroendocrine Tumors
3.1.4 Acromegally
3.1.5 Others
3.2 Global Somatostatin Receptor Type 4 Market Size by Application
3.2.1 Global Somatostatin Receptor Type 4 Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Somatostatin Receptor Type 4 Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Somatostatin Receptor Type 4 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Somatostatin Receptor Type 4 Market Size by Application
3.3.1 United States Somatostatin Receptor Type 4 Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Somatostatin Receptor Type 4 Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Somatostatin Receptor Type 4 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Somatostatin Receptor Type 4 Competitor Landscape by Company
4.1 Global Somatostatin Receptor Type 4 Market Size by Company
4.1.1 Top Global Somatostatin Receptor Type 4 Manufacturers Ranked by Revenue (2021)
4.1.2 Global Somatostatin Receptor Type 4 Revenue by Manufacturer (2017-2022)
4.1.3 Global Somatostatin Receptor Type 4 Sales by Manufacturer (2017-2022)
4.1.4 Global Somatostatin Receptor Type 4 Price by Manufacturer (2017-2022)
4.2 Global Somatostatin Receptor Type 4 Concentration Ratio (CR)
4.2.1 Somatostatin Receptor Type 4 Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Somatostatin Receptor Type 4 in 2021
4.2.3 Global Somatostatin Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Somatostatin Receptor Type 4 Manufacturing Base Distribution, Product Type
4.3.1 Global Somatostatin Receptor Type 4 Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Somatostatin Receptor Type 4 Product Type
4.3.3 Date of International Manufacturers Enter into Somatostatin Receptor Type 4 Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Somatostatin Receptor Type 4 Market Size by Company
4.5.1 Top Somatostatin Receptor Type 4 Players in United States, Ranked by Revenue (2021)
4.5.2 United States Somatostatin Receptor Type 4 Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Somatostatin Receptor Type 4 Sales by Players (2020, 2021 & 2022)
5 Global Somatostatin Receptor Type 4 Market Size by Region
5.1 Global Somatostatin Receptor Type 4 Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Somatostatin Receptor Type 4 Market Size in Volume by Region (2017-2028)
5.2.1 Global Somatostatin Receptor Type 4 Sales in Volume by Region: 2017-2022
5.2.2 Global Somatostatin Receptor Type 4 Sales in Volume Forecast by Region (2023-2028)
5.3 Global Somatostatin Receptor Type 4 Market Size in Value by Region (2017-2028)
5.3.1 Global Somatostatin Receptor Type 4 Sales in Value by Region: 2017-2022
5.3.2 Global Somatostatin Receptor Type 4 Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Somatostatin Receptor Type 4 Market Size YoY Growth 2017-2028
6.1.2 North America Somatostatin Receptor Type 4 Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Somatostatin Receptor Type 4 Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Somatostatin Receptor Type 4 Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Somatostatin Receptor Type 4 Market Size YoY Growth 2017-2028
6.3.2 Europe Somatostatin Receptor Type 4 Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Somatostatin Receptor Type 4 Market Size YoY Growth 2017-2028
6.4.2 Latin America Somatostatin Receptor Type 4 Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Somatostatin Receptor Type 4 Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Somatostatin Receptor Type 4 Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Crinetics Pharmaceuticals Inc
7.1.1 Crinetics Pharmaceuticals Inc Corporation Information
7.1.2 Crinetics Pharmaceuticals Inc Description and Business Overview
7.1.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Products Offered
7.1.5 Crinetics Pharmaceuticals Inc Recent Development
7.2 Strongbridge Biopharma plc
7.2.1 Strongbridge Biopharma plc Corporation Information
7.2.2 Strongbridge Biopharma plc Description and Business Overview
7.2.3 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Products Offered
7.2.5 Strongbridge Biopharma plc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Somatostatin Receptor Type 4 Industry Chain Analysis
8.2 Somatostatin Receptor Type 4 Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Somatostatin Receptor Type 4 Distributors
8.3 Somatostatin Receptor Type 4 Production Mode & Process
8.4 Somatostatin Receptor Type 4 Sales and Marketing
8.4.1 Somatostatin Receptor Type 4 Sales Channels
8.4.2 Somatostatin Receptor Type 4 Distributors
8.5 Somatostatin Receptor Type 4 Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Somatostatin Receptor Type 4 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Somatostatin Receptor Type 4 Market Trends
Table 3. Somatostatin Receptor Type 4 Market Drivers
Table 4. Somatostatin Receptor Type 4 Market Challenges
Table 5. Somatostatin Receptor Type 4 Market Restraints
Table 6. Global Somatostatin Receptor Type 4 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Somatostatin Receptor Type 4 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Somatostatin Receptor Type 4 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Somatostatin Receptor Type 4 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Somatostatin Receptor Type 4 Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Somatostatin Receptor Type 4 Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Somatostatin Receptor Type 4 Revenue Share by Manufacturer, 2017-2022
Table 13. Global Somatostatin Receptor Type 4 Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Somatostatin Receptor Type 4 Sales Share by Manufacturer, 2017-2022
Table 15. Global Somatostatin Receptor Type 4 Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Somatostatin Receptor Type 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Somatostatin Receptor Type 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin Receptor Type 4 as of 2021)
Table 18. Top Players of Somatostatin Receptor Type 4 in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Somatostatin Receptor Type 4 Product Type
Table 20. Date of International Manufacturers Enter into Somatostatin Receptor Type 4 Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Somatostatin Receptor Type 4 Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Somatostatin Receptor Type 4 Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Somatostatin Receptor Type 4 Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Somatostatin Receptor Type 4 Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Somatostatin Receptor Type 4 Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Somatostatin Receptor Type 4 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Somatostatin Receptor Type 4 Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Somatostatin Receptor Type 4 Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Somatostatin Receptor Type 4 Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Somatostatin Receptor Type 4 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Somatostatin Receptor Type 4 Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Somatostatin Receptor Type 4 Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Somatostatin Receptor Type 4 Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Somatostatin Receptor Type 4 Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Somatostatin Receptor Type 4 Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Somatostatin Receptor Type 4 Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Somatostatin Receptor Type 4 Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Somatostatin Receptor Type 4 Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Somatostatin Receptor Type 4 Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Somatostatin Receptor Type 4 Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Crinetics Pharmaceuticals Inc Corporation Information
Table 43. Crinetics Pharmaceuticals Inc Description and Business Overview
Table 44. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Product
Table 46. Crinetics Pharmaceuticals Inc Recent Development
Table 47. Strongbridge Biopharma plc Corporation Information
Table 48. Strongbridge Biopharma plc Description and Business Overview
Table 49. Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Strongbridge Biopharma plc Product
Table 51. Strongbridge Biopharma plc Recent Development
Table 52. Key Raw Materials Lists
Table 53. Raw Materials Key Suppliers Lists
Table 54. Somatostatin Receptor Type 4 Customers List
Table 55. Somatostatin Receptor Type 4 Distributors List
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin Receptor Type 4 Product Picture
Figure 2. Global Somatostatin Receptor Type 4 Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Somatostatin Receptor Type 4 Market Size 2017-2028 (US$ Million)
Figure 4. Global Somatostatin Receptor Type 4 Sales 2017-2028 (K Pcs)
Figure 5. United States Somatostatin Receptor Type 4 Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Somatostatin Receptor Type 4 Market Size 2017-2028 (US$ Million)
Figure 7. United States Somatostatin Receptor Type 4 Sales 2017-2028 (K Pcs)
Figure 8. United States Somatostatin Receptor Type 4 Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Somatostatin Receptor Type 4 Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Somatostatin Receptor Type 4 Report Years Considered
Figure 11. Product Picture of CNTX-0290
Figure 12. Product Picture of NNC-26910
Figure 13. Product Picture of Veldoreotide
Figure 14. Product Picture of Others
Figure 15. Global Somatostatin Receptor Type 4 Market Share by Type in 2022 & 2028
Figure 16. Global Somatostatin Receptor Type 4 Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Somatostatin Receptor Type 4 Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Somatostatin Receptor Type 4 Sales by Type (2017-2028) & (K Pcs)
Figure 19. Global Somatostatin Receptor Type 4 Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Somatostatin Receptor Type 4 Price by Type (2017-2028) & (USD/Pcs)
Figure 21. United States Somatostatin Receptor Type 4 Market Share by Type in 2022 & 2028
Figure 22. United States Somatostatin Receptor Type 4 Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Somatostatin Receptor Type 4 Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Somatostatin Receptor Type 4 Sales by Type (2017-2028) & (K Pcs)
Figure 25. United States Somatostatin Receptor Type 4 Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Somatostatin Receptor Type 4 Price by Type (2017-2028) & (USD/Pcs)
Figure 27. Product Picture of Alzheimer's Disease
Figure 28. Product Picture of Cognitive Disorders
Figure 29. Product Picture of Neuroendocrine Tumors
Figure 30. Product Picture of Acromegally
Figure 31. Product Picture of Others
Figure 32. Global Somatostatin Receptor Type 4 Market Share by Application in 2022 & 2028
Figure 33. Global Somatostatin Receptor Type 4 Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Somatostatin Receptor Type 4 Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Somatostatin Receptor Type 4 Sales by Application (2017-2028) & (K Pcs)
Figure 36. Global Somatostatin Receptor Type 4 Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Somatostatin Receptor Type 4 Price by Application (2017-2028) & (USD/Pcs)
Figure 38. United States Somatostatin Receptor Type 4 Market Share by Application in 2022 & 2028
Figure 39. United States Somatostatin Receptor Type 4 Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Somatostatin Receptor Type 4 Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Somatostatin Receptor Type 4 Sales by Application (2017-2028) & (K Pcs)
Figure 42. United States Somatostatin Receptor Type 4 Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Somatostatin Receptor Type 4 Price by Application (2017-2028) & (USD/Pcs)
Figure 44. North America Somatostatin Receptor Type 4 Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. North America Somatostatin Receptor Type 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Somatostatin Receptor Type 4 Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 49. Europe Somatostatin Receptor Type 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Somatostatin Receptor Type 4 Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 56. Asia-Pacific Somatostatin Receptor Type 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Somatostatin Receptor Type 4 Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 68. Latin America Somatostatin Receptor Type 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Somatostatin Receptor Type 4 Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 73. Middle East & Africa Somatostatin Receptor Type 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. UAE Somatostatin Receptor Type 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Somatostatin Receptor Type 4 Value Chain
Figure 78. Somatostatin Receptor Type 4 Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed